Mustang Bio, Inc.
NASDAQ · us_market
No AI insight generated yet for this ticker.
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completd Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic virus C134. It has a license agreement with city of hope national medical center and nationwide children's hospital. Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| TwoSigma | quant | 16.8K | $12.20K | 0.00% | Trimmed-58.2% | 2026-03-31 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2025-03-28 | -8.00 | 3.63 | +145.35% |
| 2024-11-08 | -6.50 | -2.00 | +69.23% |
| 2024-08-13 | -7.00 | -12.00 | -71.43% |
| 2024-05-15 | -11.00 | -23.00 | -109.09% |
| 2024-03-11 | -67.00 | -35.50 | +47.01% |
| 2023-11-14 | -77.50 | -69.81 | +9.92% |
| 2023-08-14 | -85.75 | -100.00 | -16.62% |
| 2023-05-12 | -150.50 | -103.00 | +31.56% |
| 2023-03-29 | -146.25 | -135.00 | +7.69% |
| 2022-11-14 | -147.50 | -135.00 | +8.47% |
| 2022-08-11 | -155.00 | -142.50 | +8.06% |
| 2022-05-12 | -140.00 | -150.00 | -7.14% |
| 2022-03-23 | -142.50 | -165.00 | -15.79% |
| 2021-11-12 | -127.50 | -142.50 | -11.76% |
| 2021-08-16 | -142.50 | -120.00 | +15.79% |
| 2021-05-14 | -127.50 | -142.50 | -11.76% |
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| MBIO | -11.14% | -27.65% | -31.70% | -48.85% |
| XLV | +2.97% | -4.64% | -3.44% | +12.69% |
| Alpha (stock − sector) | -14.11% | -23.01% | -28.26% | -61.54% |